#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Biliary cancer metastatic Gaucher's disease type I Chondrosarcoma metastatic Glomerulonephritis membranoproliferative Mucopolysaccharidosis II Usher's syndrome Richter's syndrome Univentricular heart Adult T-cell lymphoma/leukaemia refractory Fibrosarcoma Retinoblastoma Cortical dysplasia Duchenne muscular dystrophy gene carrier Lymphangiosarcoma Non-Hodgkin's lymphoma unspecified histology aggressive recurrent More trials…

    Learn about Rare Diseases

    Testicular leiomyosarcoma – Treatment Congenital generalised lipodystrophy – Diagnostics Adrenocortical carcinoma – Basic Information Pulmonary fibrosis – Basic Information Brain stem glioma – Diagnostics Hereditary motor and sensory neuropathy – Trials in Disease Prader-Willi syndrome – Life with Disease Mastocytosis – Life with Disease Pemphigus Turner’s syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Emapalumab Soticlestat Prednisolone Sodium Phosphate Magnesium Inclisiran Sodium Patisiran Valaciclovir Balcinrenone Bms-986458 Methoxyflurane Dextromethorphan Hydrobromide Atuliflapon Pentosan Polysulfate Sodium Abc-16F-116 RO7268489 Gemcitabine Hydrochloride Alrefimotide Valiltramiprosate SARACATINIB Darbepoetin Alfa More therapies…

    Learn about Your Condition

    Tachypnoea Hyperplasia adrenal Carcinoid tumour pulmonary Anal cancer stage III Mucosal inflammation Metastases to liver Exposure via breast milk Adenomyosis Acute respiratory failure Noonan syndrome Cerebral haemorrhage Hypoxia Intestinal ischaemia Ependymoma malignant Gender dysphoria More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Ireland

  • Pumitamig Versus Durvalumab in Patients With Unresectable Stage III Non-Small Cell Lung Cancer Without Progression After Chemoradiation

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage III
    Investigated Drugs:
    • Durvalumab
    Austria Belgium Bulgaria France Germany Greece +8
  • Safety and Efficacy of Sodium Phenylbutyrate Eye Drops in Children with Myopia

    Recruiting

    2 1
    Investigated Drugs:
    • Sodium Phenylbutyrate
    Austria Ireland
  • A Study of BI 764532, Atezolizumab, Carboplatin, and Etoposide in Patients With Extensive-Stage Small Cell Lung Cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Atezolizumab
    • Carboplatin
    • Etoposide
    Austria Belgium Bulgaria Czechia Estonia Finland +14
  • Phase 3 Study of LY4170156 (Sofetabart Mipitecan) with drug combination in platinum‑resistant and platinum‑sensitive ovarian cancer patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Fallopian tube cancer
    • Ovarian cancer metastatic
    • Ovarian cancer
    Investigated Drugs:
    • Mirvetuximab Soravtansine
    • LY4170156
    • Topotecan
    Austria Belgium Czechia Denmark France Germany +9
  • A study of sacituzumab tirumotecan and bevacizumab in patients with newly diagnosed advanced ovarian cancer following first-line platinum-based chemotherapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Ovarian cancer
    Investigated Drugs:
    • Sacituzumab Tirumotecan
    • Bevacizumab
    Austria Belgium Czechia Denmark Finland France +9
  • A study to evaluate the safety and effectiveness of pegtibatinase in patients aged 12 to 65 years with classical homocystinuria.

    Recruiting

    3 1
    Belgium France Germany Ireland Italy Poland +2
Previous Page
1 2 3 4 … 75
Next Page

Find Clinical Trials in Your Selected Region and City

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Pembrolizumab Carboplatin Paclitaxel Cisplatin Dexamethasone Docetaxel Gemcitabine Doxorubicin Hydrochloride Prednisolone Sodium Chloride Enzalutamide Cyclophosphamide Pemetrexed Paclitaxel Albumin-Bound Paracetamol Bevacizumab Hydrocortisone Etoposide Venetoclax Nivolumab Lenalidomide Capecitabine Anastrozole Oxaliplatin Rituximab Fluorouracil Durvalumab Buclizine Hydrochloride Codeine Phosphate Letrozole Show more

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

ABO haemolytic disease of newborn Acquired ATTR amyloidosis Acute lymphocytic leukaemia Acute lymphocytic leukaemia recurrent Acute myeloid leukaemia Addison's disease Adenocarcinoma gastric Adenocarcinoma pancreas Adrenogenital syndrome Alpha-1 antitrypsin deficiency Alveolar proteinosis Amyotrophic lateral sclerosis Anaemia Anaemia of pregnancy Anti-glomerular basement membrane disease Antiphospholipid antibodies Arteriosclerosis Asthma Autonomic nervous system imbalance B-cell small lymphocytic lymphoma B-cell small lymphocytic lymphoma recurrent B-cell small lymphocytic lymphoma refractory Barth syndrome Biliary neoplasm Bladder cancer Bladder cancer stage II Bladder cancer stage III Bladder transitional cell carcinoma Breast cancer Breast cancer female Breast cancer male Breast cancer metastatic Breast cancer recurrent Breast cancer stage I Breast cancer stage II Breast cancer stage III Bronchiectasis Bronchopulmonary dysplasia Cachexia Carcinoid syndrome Cardiac amyloidosis Cardiac failure Cardiomyopathy Cardiovascular disorder CDKL5 deficiency disorder Central nervous system neoplasm Cerebrovascular accident Cervix carcinoma Cervix carcinoma recurrent Cholangiocarcinoma Chondrosarcoma Choroid melanoma Chronic graft versus host disease Chronic inflammatory demyelinating polyradiculoneuropathy Chronic left ventricular failure Chronic lymphocytic leukaemia Chronic lymphocytic leukaemia recurrent Chronic obstructive pulmonary disease Clear cell renal cell carcinoma Clostridium difficile infection Coeliac disease Colitis ulcerative Colon cancer Colorectal cancer Colorectal cancer metastatic Coronary artery disease COVID-19 Critical illness Crohn's disease Cystic fibrosis Cystic fibrosis respiratory infection suppression Decreased appetite Dementia Alzheimer's type Dermatitis atopic Diffuse large B-cell lymphoma Drug dependence Dry age-related macular degeneration Duchenne muscular dystrophy Duchenne muscular dystrophy gene carrier Elderly Embolic stroke Embolism venous Emphysema Endometrial adenocarcinoma Endometrial cancer Endometrial cancer recurrent Ependymoma Epidermolysis bullosa Factor IX deficiency Factor VIII deficiency Fallopian tube cancer Familial hypertriglyceridaemia Follicle centre lymphoma follicular grade I, II - III Follicular lymphoma Food allergy Fragile X syndrome Gastric cancer Gastrointestinal cancer metastatic Gastrooesophageal cancer Generalised tonic-clonic seizure Glioblastoma Glomerulonephritis membranous Haemolytic uraemic syndrome Haemophilia Hepatobiliary cancer Hepatoblastoma Hepatocellular carcinoma HER2 positive breast cancer Hereditary angioedema Hereditary angioedema with C1 esterase inhibitor deficiency Hereditary haemochromatosis Hidradenitis HIV infection Hodgkin's disease Homocystinuria Hormone receptor positive breast cancer Hormone receptor positive HER2 negative breast cancer Hormone-dependent prostate cancer Hormone-refractory prostate cancer Hot flush Huntington's disease Hypergammaglobulinaemia benign monoclonal Hypertension Hypertrophic cardiomyopathy Hypoxic-ischaemic encephalopathy Idiopathic inflammatory myopathy Idiopathic pulmonary fibrosis Immune thrombocytopenia Indolent systemic mastocytosis Interstitial lung disease Iron deficiency anaemia Juvenile idiopathic arthritis K-ras gene mutation Left ventricular dysfunction Lung disorder Lung neoplasm malignant Lymphatic malformation Major depression Malignant glioma Malignant melanoma Malignant neoplasm of choroid Malignant peritoneal neoplasm Mantle cell lymphoma Marginal zone lymphoma Mechanical ventilation Metabolic dysfunction-associated steatohepatitis Metastatic renal cell carcinoma Monkeypox Monkeypox immunisation Myelodysplastic syndrome Myelodysplastic syndrome with excess blasts Myelofibrosis Myopia Myotonic dystrophy Neoplasm Neoplasm malignant Neovascular age-related macular degeneration Nephrogenic anaemia Nephropathy Neuroblastoma Non-alcoholic steatohepatitis Non-Hodgkin's lymphoma Non-small cell lung cancer Non-small cell lung cancer metastatic Non-small cell lung cancer recurrent Non-small cell lung cancer stage II Non-small cell lung cancer stage III Non-small cell lung cancer stage IIIA Non-small cell lung cancer stage IIIB Non-small cell lung cancer stage IV NTRK gene fusion overexpression Obesity Oesophageal adenocarcinoma Oesophageal adenocarcinoma stage II Oesophageal adenocarcinoma stage III Oesophageal carcinoma Oesophageal squamous cell carcinoma Oesophageal squamous cell carcinoma stage II Oesophageal squamous cell carcinoma stage III Open angle glaucoma Oropharyngeal cancer Osteochondrodysplasia Osteogenesis imperfecta Osteosarcoma Ovarian cancer Ovarian cancer metastatic Ovarian cancer recurrent Ovarian cancer stage III Ovarian epithelial cancer Ovarian epithelial cancer recurrent Overweight Pancreatic carcinoma Pancreatic carcinoma metastatic Paroxysmal nocturnal haemoglobinuria Partial seizures Patent ductus arteriosus PD-L1 positive cancer Phenylketonuria PIK3CA related overgrowth spectrum PIK3CA-activated mutation Plasma cell myeloma Plasma cell myeloma refractory Pneumonia Polycythaemia vera Polyneuropathy Porphyria non-acute Post-traumatic stress disorder Postoperative wound infection Premature baby Primary amyloidosis Primary myelofibrosis Procedural pain Prostate cancer Prostate cancer metastatic Psoriatic arthropathy Pulmonary arterial hypertension Pulmonary fibrosis Rectal cancer Relapsing multiple sclerosis Renal cancer metastatic Renal cell carcinoma Renal cell carcinoma stage IV Respiratory tract infection Retinal artery occlusion Rhabdomyosarcoma Richter's syndrome Secondary progressive multiple sclerosis Serous cystadenocarcinoma ovary Sickle cell disease Sjogren's syndrome Small cell lung cancer Small cell lung cancer extensive stage Small cell lung cancer recurrent Spinal muscular atrophy Squamous cell carcinoma Squamous cell carcinoma of head and neck Squamous cell carcinoma of lung Squamous cell carcinoma of skin Systemic lupus erythematosus Systemic mastocytosis Systemic scleroderma Testicular germ cell cancer Transitional cell cancer of the renal pelvis and ureter Transitional cell carcinoma Transitional cell carcinoma metastatic Transitional cell carcinoma urethra Triple negative breast cancer Type 2 diabetes mellitus Uveal melanoma Vascular malformation Von Willebrand's disease Waldenstrom's macroglobulinaemia

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!